RIGEL PHARMACEUTICALS INC (RIGL) › Operating Cash FlowRIGEL PHARMACEUTICALS INC (RIGL) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2015: -$23.41M2016: -$75.89M2017: -$77.56M2018: -$58.83M2019: -$41.51M2020: -$52.19M2021: $5.88M2022: -$73.76M2023: -$5.74M2024: $31.47M2025: $75.66M$75.66M2015Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025$75.66M+140.4%2024$31.47M+648.0%2023-$5.74M+92.2%2022-$73.76M-1354.8%2021$5.88M+111.3%2020-$52.19M-25.7%2019-$41.51M+29.4%2018-$58.83M+24.2%2017-$77.56M-2.2%2016-$75.89M-224.1%2015-$23.41M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share